The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 16th 2025
Aficamten, a cardiac myosin inhibitor, gains FDA approval, offering hope for improved cardiovascular health in patients with obstructive hypertrophic cardiomyopathy.
ASHP Discusses Grant Received From American Rescue Plan
January 28th 2022Anna Legreid Dopp, PharmD, the Senior Director of Clinical Guidelines & Quality Improvement at ASHP, and Bayli Larson, PharmD, the Strategic Initiatives Associate at ASHP, discuss the grant the ASHP received from the American Rescue Plan.
Watch
Expert: Mark Cuban Cost Plus Drug Company Raises Questions, But May Not Be Cause for Concern
January 27th 2022Ron Lanton III, Esq, principal at Lanton Law, said entrepreneur Mark Cuban's new venture into the pharmacy field is very interesting, although it maybe just another player in the mail-order pharmacy market.
Watch
Is a 90-Day Supply the Best Option to Improve Medication Adherence?
Interventions to improve medication adherence may have a greater impact on individual patients and the population as a whole than any novel treatment or therapy.
Read More
Pfizer, BioNTech to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age
January 27th 2022The study will have 3 cohorts examining different regimens of the current Pfizer-BioNTech COVID-19 vaccine or an omicron-based vaccine and will use participants from the phase 3 COVID-19 booster study.
Read More